Daniel C Malone
Daniel C Malone
Professor of Pharmacy, University of Utah
Bestätigte E-Mail-Adresse bei utah.edu
Zitiert von
Zitiert von
A national estimate of the economic costs of asthma
DH Smith, DC Malone, KA Lawson, LJ Okamoto, C Battista, WB Saunders
American journal of respiratory and critical care medicine 156 (3), 787-793, 1997
Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures
LM Hess, MA Raebel, DA Conner, DC Malone
Annals of pharmacotherapy 40 (7-8), 1280-1288, 2006
Excessive antibiotic use for acute respiratory infections in the United States
R Gonzales, DC Malone, JH Maselli, MA Sande
Clinical infectious diseases 33 (6), 757-762, 2001
A cost of illness study of allergic rhinitis inthe United States
DC Malone, KA Lawson, DH Smith, HM Arrighi, C Battista
Journal of Allergy and Clinical Immunology 99 (1), 22-27, 1997
Health services use and health care costs of obese and nonobese individuals
MA Raebel, DC Malone, DA Conner, S Xu, JA Porter, FA Lanty
Archives of internal medicine 164 (19), 2135-2140, 2004
Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation
AR Harrington, EP Armstrong, PE Nolan Jr, DC Malone
Stroke 44 (6), 1676-1681, 2013
Concordance of severity ratings provided in four drug interaction compendia
J Abarca, DC Malone, EP Armstrong, AJ Grizzle, PD Hansten, ...
Journal of the American Pharmacists Association 44 (2), 136-141, 2004
Identification of serious drug–drug interactions: results of the partnership to prevent drug–drug interactions
DC Malone, EP Armstrong, J Abarca, AJ Grizzle, PD Hansten, ...
Journal of the American Pharmacists Association 44 (2), 142-151, 2004
Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study
SL Ellis, BL Carter, DC Malone, SJ Billups, GJ Okano, RJ Valuck, ...
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 20 (12 …, 2000
The relationship between drug therapy noncompliance and patient characteristics, health‐related quality of life, and health care costs
SJ Billups, DC Malone, BL Carter
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 20 (8 …, 2000
Health care utilization and costs by metabolic syndrome risk factors
DM Boudreau, DC Malone, MA Raebel, PA Fishman, GA Nichols, ...
Metabolic syndrome and related disorders 7 (4), 305-314, 2009
Social media mining for toxicovigilance: automatic monitoring of prescription medication abuse from Twitter
A Sarker, K O’connor, R Ginn, M Scotch, K Smith, D Malone, G Gonzalez
Drug safety 39 (3), 231-240, 2016
Costs of {beta}-Lactam Allergies: Selection and Costs of Antibiotics for Patients With a Reported {beta}-Lactam Allergy
EJ MacLaughlin, JJ Saseen, DC Malone
Archives of family medicine 9 (8), 722, 2000
Recommendations to improve the usability of drug-drug interaction clinical decision support alerts
TH Payne, LE Hines, RC Chan, S Hartman, J Kapusnik-Uner, AL Russ, ...
Journal of the American Medical Informatics Association 22 (6), 1243-1250, 2015
Assessment of potential drug–drug interactions with a prescription claims database
DC Malone, DS Hutchins, H Haupert, P Hansten, B Duncan, ...
American journal of health-system pharmacy 62 (19), 1983-1991, 2005
Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards
A Bottomley, M Pe, J Sloan, E Basch, F Bonnetain, M Calvert, A Campbell, ...
The Lancet Oncology 17 (11), e510-e514, 2016
An economic analysis of a randomized, controlled, multicenter study of clinical pharmacist interventions for high‐risk veterans: the IMPROVE study
DC Malone, BL Carter, SJ Billups, RJ Valuck, DJ Barnette, CD Sintek, ...
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 20 (10 …, 2000
Challenges in the development and reimbursement of personalized medicine—payer and manufacturer perspectives and implications for health economics and outcomes research: a …
E Faulkner, L Annemans, L Garrison, M Helfand, AP Holtorf, J Hornberger, ...
Value in Health 15 (8), 1162-1171, 2012
Ability of pharmacy clinical decision-support software to alert users about clinically important drug—drug interactions
KR Saverno, LE Hines, TL Warholak, AJ Grizzle, L Babits, C Clark, ...
Journal of the American Medical Informatics Association 18 (1), 32-37, 2011
Practitioners' Views on Computerized Drug—Drug Interaction Alerts in the VA System
Y Ko, J Abarca, DC Malone, DC Dare, D Geraets, A Houranieh, WN Jones, ...
Journal of the American Medical Informatics Association 14 (1), 56-64, 2007
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20